Webinar: FluoroSpot assay qualification for use in clinical trials
This joint webinar by Mabtech and IQVIA Laboratories provides practical guidance on qualifying and validating FluoroSpot assays for clinical use. It covers key regulatory considerations, assay selection, experimental design, and best practices for working with clinical samples, controls, and workflows to ensure robust and reliable results in clinical trials.
Online
FluoroSpot enables sensitive, multiplex analysis of antigen-specific T-cell and B-cell responses. But what does it take to qualify it for clinical use?
In this joint webinar, Mabtech and IQVIA Laboratories share practical insights from clinical trial settings.
We will cover key considerations for assay qualification and validation, and walk through how to design and evaluate FluoroSpot qualification experiments.
Practical aspects such as sample quality, peptide selection, assay controls, and workflow optimization will be highlighted to support reliable, high-quality results.
Key topics include:
- When FluoroSpot is the right choice for your study
- How to approach assay selection in clinical trials
- Key regulatory considerations for qualification and validation
- How to design and evaluate qualification experiments
- Practical guidance for working with clinical samples and controls
Speaker
Renata Varnaitė
PhD in infectious disease immunology from the Karolinska Institutet
Field Application Specialist at Mabtech
Aurélie Mazy
Master’s degree in Biomedical Sciences with a specialization in Immunopathology
Scientist and Team Lead of the Immunogenicity department at IQVIA Laboratories
Sofie Denies
Master’s degree in Statistics and PhD in Immuno‑Oncology
Biostatistician at IQVIA Laboratories
Related images
